ECM
ANIK icon

ExodusPoint Capital Management’s Anika Therapeutics ANIK Stock Holding History

ExodusPoint Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,039
Closed -$264K – 1436
2024
Q4 		$264K Buy
+16,039
New +$316K ﹤0.01% 1311
2024
Q2 		– Sell
-15,562
Closed -$395K – 1502
2024
Q1 		$395K Buy
15,562
+29
+0.2% +$702 ﹤0.01% 1193
2023
Q4 		$352K Buy
+15,533
New +$321K ﹤0.01% 1131
2023
Q3 		– Sell
-10,236
Closed -$266K – 1673
2023
Q2 		$266K Buy
+10,236
New +$274K ﹤0.01% 1584
2020
Q4 		– Sell
-8,030
Closed -$284K – 1932
2020
Q3 		$284K Buy
+8,030
New +$290K 0.01% 1317
2020
Q1 		– Sell
-10,725
Closed -$556K – 1061
2019
Q4 		$556K Buy
10,725
+1,557
+17% +$90.4K 0.02% 801
2019
Q3 		$503K Buy
+9,168
New +$471K 0.02% 657

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $254M AUM 98.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return